Seragon Publishes Data on Longevity Drug SRN-901, Showing Record-Breaking Lifespan Extension in Mice SRN-901 extends lifespan 33% and reduces frailty by 70%, reshaping aging biology through coordinated, multi-pathway intervention. April 29, 2026 Biotechnology·Health·Products & Supplements·Science·Technology
Seragon’s SRN-901: Breakthrough Aging Intervention Drug Achieves Dramatic Lifespan Extension in Preclinical Study In a May 7, 2024 press release, Seragon Biosciences announced that its aging intervention drug candidate, SRN-901, achieved one of the largest extensions of March 20, 2025 Biotechnology·Health·Science·Technology
Old Blood, Fast Aging: How a Human Organ-Chip Reveals the Biology of Systemic Aging April 29, 2026 A 2026 Nature Biomedical Engineering study shows how old human
Seragon Publishes Data on Longevity Drug SRN-901, Showing Record-Breaking Lifespan Extension in Mice April 29, 2026 SRN-901 extends lifespan 33% and reduces frailty by 70%, reshaping
Ferro-Aging: Iron and Lipid Damage May Be Driving Aging at Its Core April 24, 2026 A new Cell Metabolism study reveals ferro-aging, linking iron, lipid
Senescent Macrophages Aren’t What We Thought: A New Cell State Rewires Inflammaging April 21, 2026 A 2026 Nature Aging paper identifies a distinct p21+TREM2+ senescent